Pfizer

Pfizer discontinues development of ‘obesity drug taken twice a day’ due to side effects… stock price falls 5%

by

2023-12-02 05:20:27 American pharmaceutical company Pfizer has discontinued the development of an obesity treatment drug that requires taking two pills a day. Pfizer announced on the 1st (local time) that it was discontinuing the development of Danuglyprone, an obesity treatment drug taken twice a day, saying, “The rate of side effects and discontinuation of medication … Read more

The Pfizer company is in the red: due to the drop in demand for vaccines, the company has lost several billions

by

2023-10-31 15:30:00 American pharmaceutical company Pfizer found itself in the red in the third quarter due to falling demand for Covid vaccines. The company recorded a loss of $2.4 billion (2.3 billion euros) from July to September, while it had made a profit of more than $8.6 billion over the same period l ‘last year. … Read more

Pharmaceutical company Pfizer suffers significant losses after demand for corona shots falls | Economy

by

2023-10-31 20:16:05 Door onze economieredactie 31 okt 2023 om 15:07 Update: 5 uur geleden The American pharmaceutical company Pfizer suffered a loss of billions in the third quarter. This was mainly due to collapsed demand for its corona vaccines. The group suffered a loss of 2.4 billion dollars (about 2.3 billion euros) in the past … Read more

Prevenar 13: Pfizer Pharmaceuticals Korea Launches National Pneumococcal and Influenza Vaccination Campaign

by

2023-10-27 05:55:53 Pfizer Pharmaceuticals Korea conducts pneumococcal and influenza vaccination campaign Entered 2023.10.27 14:55 Views 33 Entered 2023.10.27 14:55 Views 33 Pfizer Korea’s Prevenar 13, pneumococcal + flu vaccination campaign. [사진=한국화이자제약]Pfizer Pharmaceuticals Korea announced on the 27th that it will hold a campaign to raise awareness of the importance of pneumococcal and influenza vaccination for … Read more

In the pipeline: Guerbet, AbbVie, Pfizer

by

2023-10-20 07:00:00 Positive opinion from the CHMP for Guerbet The EMA CHMP has positioned itself in favor of the European Marketing Authorization ofElucidate (gadopiclenol) Guerbet in its indication for magnetic resonance imaging with contrast enhancement, in patients over two years old. This decision is based on phase III results which demonstrated that an MRI examination … Read more

Controversial revelation: Simian Virus 40 (SV40) found in Pfizer coronavirus vaccine exposes potential cancer risk

by

2023-10-19 17:14:35 Exclusive translation: The Canadian Ministry of Health announced the presence of the DNA sequence of the Simian Virus 40 (SV40) in the Pfizer coronavirus vaccine, which the manufacturer had not previously disclosed, as some scientists say this virus may cause cancer. They identified the virus earlier “Health Canada expects sponsors to identify any … Read more